Recent Transactions

27-Nov-19
$320 million
United States flag
Target: 

David’s Bridal Inc.

flag not available
Acquiror: 
N/A

Advised David’s Bridal, a leading bridal gown and special occasion dress retailer, on its out-of-court recapitalization

17-Jun-16
$310 million
United Kingdom flag
Target: 

Dobbies Garden Centres

United Kingdom flag
Acquiror: 
Investor group led by Midlothian Capital Partners and Hattington Capital

Advised Tesco plc, a listed FTSE 100 retailer, on its sale of Dobbies Garden Centres to an investor group led by Midlothian Capital Partners and Hattington Capital

22-Dec-16
$290 million
Chile Flag
Target: 

Subsidiaries and affiliates of Empresas Indumotora S.A.

United Kingdom flag
Acquiror: 
Inchcape PLC

Advised Inchcape PLC, a global leader in automotive retail and distribution, on the acquisition of a multi-country scale distribution business in Chile, Peru, Colombia, and Argentina for $290m (approximately £234m)

26-Mar-18
$284 million
Panama, Costa Rica Flags
Target: 

Grupo Rudelman

United Kingdom flag
Acquiror: 
Inchcape PLC

Advised Inchcape PLC, a global leader in automotive and distribution, on the acquisition of Grupo Rudelman, a Suzuki-focused distribution business in Costa Rica and Panama

13-Dec-10
$256 million
United Kingdom flag
Target: 

Maxinutrition Group Holdings Limited

United Kingdom flag
Acquiror: 
GlaxoSmithKline Plc

Advised GlaxoSmithKline Plc, the UK listed international pharmaceutical and consumer company, on its acquisition of Maxinutrition Group Holdings Limited, a UK based sports nutrition business, from Darwin Private Equity

11-May-17
$245 million
Saudi Arabia Flag
Target: 

Equity stake in Bupa Arabia

United Kingdom flag
Acquiror: 
Bupa Ltd.

Advised Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, one of the largest health insurance providers in the Kingdom of Saudi Arabia

01-Jul-20
$225 million
United Kingdom flag
Target: 

Cello Health plc

United States flag
Acquiror: 
Arsenal Capital Partners

Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

16-Feb-23
Pending
$220 million
U.S.A., U.K. flags
Target: 

Flavor Specialty Ingredients division of IFF

United Kingdom flag
Acquiror: 
Exponent Private Equity

Sole financial adviser to Exponent, one of the UK’s leading private equity firms, on the acquisition of IFF’s Flavor Specialty Ingredients division, a global leader in the base aromas market

23-Jan-23
Pending
$200 million
United Kingdom flag
Target: 

Clinigen Ltd’s Proleukin

United States flag
Acquiror: 
Iovance Biotherapeutics

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies

30-Oct-18
$198 million
United States flag
Target: 

InMotion Entertainment Group LLC

United Kingdom flag
Acquiror: 
WH Smith plc

Advised WH Smith plc, one of the UK’s leading retailers, on the acquisition of InMotion Entertainment, the market leading retailer of digital accessories in US airports

06-Dec-18
$165 million
Germany flag
Target: 

Storz & Bickel GmbH, related entities and IP

Canada flag
Acquiror: 
Canopy Growth Corporation

Advised Canopy Growth, a leading diversified cannabis company, on its acquisition of Storz & Bickel, a premium manufacturer of vaporization devices

04-Oct-18
$154 million
United Kingdom flag
Target: 

Larger non-controlled assets of Electra Private Equity plc

United Kingdom flag
Acquiror: 
Lexington Partners

Advised Electra Private Equity plc, a UK-listed private equity investment trust, on its strategic review and subsequent sale of the larger non-controlled assets of Photobox and Knight Square to funds managed by Lexington Partners

10-Jun-20
$134 million
Saudi Arabia Flag
Target: 

Equity stake in Bupa Arabia

United Kingdom flag
Acquiror: 
Bupa Ltd.

Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia,  the largest health insurance provider in the Kingdom of Saudi Arabia

17-Dec-15
$130 million
Swiss, Netherlands flags
Target: 

Airopack Technology Group AG

United States flag
Acquiror: 
Apollo Global Management, LLC

Advised Airopack Technology Group, developer of a revolutionary all-plastic dispenser, on a €120 million debt and equity investment from funds managed by affiliates of Apollo Global Management, and the concurrently announced proposed acquisition of the 50% stake it does not already own in Airolux AG, its joint venture with Resilux NV

26-Apr-23
Pending
$127 million
Australia flag
Target: 

Marley Spoon business combination with 468 SPAC II

Germany flag
Acquiror: 
468 SPAC II SE

Advising Marley Spoon SE, an ASX listed global subscription-based meal kit provider, on its business combination agreement with 468 SPAC II, simultaneous capital raising and amendment to existing debt facilities

23-Nov-20
$120 million
United Kingdom flag
Target: 

Greencore Group plc

flag not available
Acquiror: 
N/A

Advised Greencore Group plc, a leading UK manufacturer of convenience foods based in Ireland, on its £90mm non pre-emptive equity placing

20-Feb-13
$120 million
Australia flag
Target: 

Trivett Automotive Group

United Kingdom flag
Acquiror: 
Inchcape plc

Advised Inchcape plc, the leading independent international automotive distributor and retailer, on the acquisition of Trivett Automotive Group, the leading luxury and premium automotive group in Australia

26-Nov-10
$118 million
Australia flag
Target: 

Healthcare Australia

United Kingdom flag
Acquiror: 
Healthcare Locums

Advised CHAMP Private Equity on the sale of Healthcare Australia, a leading provider of nursing agency staff to public and private health institutions in Australia, to Healthcare Locums, a healthcare recruitment agency based in the UK

29-Dec-20
$110 million
United States flag
Target: 

Biogix, Inc.

United Kingdom flag
Acquiror: 
Alliance Pharma plc

Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc

28-Mar-22
Pending
$105 million
United Kingdom flag
Target: 

Acacia Pharma Group plc

United States flag
Acquiror: 
Eagle Pharmaceuticals, Inc.

Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise

23-May-18
$93 million
United Kingdom flag
Target: 

Dairy Crest Group PLC

flag not available

Advised Dairy Crest, a leading British dairy company, on a non-pre-emptive cash placing, raising proceeds of approximately £70 million

21-May-08
$85 million
United Kingdom flag
Target: 

Dobbies Garden Centres plc

United Kingdom flag
Acquiror: 
Tesco plc

Advised Tesco plc in relation to its public cash offer to acquire the 35% of Dobbies Garden Centres plc which it does not already own

04-May-12
$55 million
United Kingdom flag
Target: 

Armajaro Trading Limited

United States flag
Acquiror: 
International Finance Corporation

Advised Armajaro Trading Limited, a global soft commodity trading house and supply chain manager, on raising mezzanine capital from the International Finance Corporation, a unit of the World Bank

01-Oct-08
$53 million
Sweden flag
Target: 

Biotage (Biosystems division)

Netherlands flag
Acquiror: 
Qiagen NV

Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research

Pages

show all